Brief: FDA Confirms Eligibility Of XORLO For Accelerated Approval
04/05/2023 12:13
May 4 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* FDA CONFIRMS ELIGIBILITY OF XORLO™ FOR ACCELERATED
APPROVAL
Source text for Eikon: ID:nGNX2N4x2Y
Further company coverage: XRTX.V
((Reuters.Brief@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering